B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome

REACTOME PATHWAY
Reactome: R-HSA-56784201 genes2 compounds

The Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome pathway (Reactome ID: R-HSA-5678420) involves 1 genes and is affected by 2 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ABCC9

Compounds Affecting Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome

#CompoundTargets HitStudies
1Cromakalim300
2Glyburide298

About the Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome Pathway

The Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome pathway is catalogued in Reactome (ID: R-HSA-5678420) and involves 1 genes. In the BiohacksAI corpus, 2 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ABCC9.